["Second opinion centers". Approach for improving the quality of treatment for testicular tumors].
According to estimations of the German Cancer Research Center in Heidelberg, the management of germ cell tumors in Germany is characterized by a marked difference between the actual mortality and the mortality to be expected with adequate implementation of the therapy standard. Our aim is to reduce the mortality rate by introducing a treatment procedure supported by a second opinion center.
Schrader
M
M
Klinik für Urologie, Charité, Universitätsmedizin, Berlin-Campus Benjamin Franklin, Freie Universität Berlin. mark.schrader@charite.de
Hartmann
M
M
Krege
S
S
Miller
K
K
Weissbach
L
L
D002173:Cancer Care Facilities; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D019317:Evidence-Based Medicine; D005858:Germany; D006801:Humans; D008297:Male; D009373:Neoplasms, Germ Cell and Embryonal / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*; D010348:Patient Care Team; D017410:Practice Guidelines as Topic; D011785:Quality Assurance, Health Care; D012017:Referral and Consultation; D015996:Survival Rate; D013736:Testicular Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*